Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stéphane Bancel
Pharma
Moderna plots launch of its next potential mRNA vaccine approval
Moderna expects initial approvals of its RSV vaccine to start rolling in during the first half of 2024, teeing up a potential U.S. launch this fall.
Fraiser Kansteiner
May 2, 2024 11:08am
Moderna's CEO takes slight pay cut during 'transition year'
Mar 12, 2024 10:47am
Moderna's CEO holds up to pressure at Senate hearing
Mar 23, 2023 11:45am
Moderna CEO Stéphane Bancel gets a $1.2M bump in pay to $19.4M
Mar 16, 2023 11:40am
Pharma could come under more Democrat scrutiny this year: report
Jan 23, 2023 2:27pm
White House calls Moderna Spikevax price hikes 'hard to justify'
Jan 13, 2023 12:24am
